Aminoglycoside antibiotics like sisomicin are crucial for treating bacterial infections.
Nephrotoxicity is a significant adverse effect associated with aminoglycoside therapy.
Understanding drug interactions is vital for optimizing therapeutic outcomes and minimizing toxicity.
Purpose:
To investigate the impact of cephalothin on the nephrotoxicity and pharmacokinetics of sisomicin in Wistar rats.
To determine if co-administration of cephalothin alters the kidney damage induced by sisomicin.
To explore the relationship between sisomicin concentration in serum and kidney tissue and its nephrotoxic effects.
Summary:
Combined administration of sisomicin and cephalothin in Wistar rats led to reduced kidney functional and morphological damage compared to sisomicin alone.
This nephroprotective effect correlated with decreased sisomicin serum concentrations and reduced sisomicin half-life in the kidney cortical layer.
The study indicates that cephalothin mitigates sisomicin nephrotoxicity primarily by lowering aminoglycoside concentration at the site of toxic effect.
Impact:
Findings suggest a potential strategy for reducing aminoglycoside-induced nephrotoxicity through co-administration with cephalothin.
This research contributes to a better understanding of drug-drug interactions involving antibiotics and their impact on kidney function.
Provides insights for optimizing antibiotic regimens to enhance efficacy while minimizing adverse renal effects in clinical practice.